title: Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
abstract: Final adult height is often compromised in children with congenital adrenal hyperplasia (CAH). This study examines the impact of GH and LHRH analog (LHRHa) on final adult height in patients with CAH due to 21-hydroxylase deficiency. Fourteen patients with CAH (eight males, six females) predicted to be more than 1.0 sd below their midparental target height received GH and LHRHa until final height. Each patient was matched at the start of GH therapy to a CAH patient treated only with glucocorticoids according to type of CAH, sex, and chronological age. Mean age, bone age, height, height prediction, and target height were the same in both groups at the beginning of GH therapy. Mean duration of GH treatment was 4.4 +/- 1.5 yr. Mean duration of LHRHa therapy was 4.2 +/- 2.0 yr. In the treatment group, final height sd score of -0.4 + 0.8 was significantly greater than both the initial prediction of -1.5 +/- 0.9 (P < 0.0001) and the final height sd score of the untreated group of -1.4 +/- 1.1 (P = 0.01). Our results indicate that the combination of GH and LHRHa improves final adult height in patients with CAH.
authors.affiliation: Department of Pediatrics, Mount Sinai Medical Center, 1 Gustave L. Levy Place, Box 1198, New York, New York 10029, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Lin-Su
authors.forename: Maria G
authors.initials: MG
authors.lastname: Vogiatzi
authors.forename: Ian
authors.initials: I
authors.lastname: Marshall
authors.forename: Madeleine D
authors.initials: MD
authors.lastname: Harbison
authors.forename: Maria C
authors.initials: MC
authors.lastname: Macapagal
authors.forename: Brian
authors.initials: B
authors.lastname: Betensky
authors.forename: Susan
authors.initials: S
authors.lastname: Tansil
authors.forename: Maria I
authors.initials: MI
authors.lastname: New
mesh_terms: D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy*; D000328:Adult; D001827:Body Height / Q000187:drug effects*; D002648:Child; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006128:Growth / Q000187:drug effects / Q000502:physiology; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D019382:Human Growth Hormone; D007987:Gonadotropin-Releasing Hormone